Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese and western medicine pharmaceutical composition for inhibiting novel coronavirus

A coronavirus and composition technology, applied in antiviral agents, pharmaceutical formulas, active ingredients of heterocyclic compounds, etc., can solve the problems of Chinese and Western medicine compositions without coronavirus COVID-19, and prevent RNA viruses from penetrating Effects of host cells, inhibition of topoisomerase activity, and inhibition of influenza virus neuraminidase

Pending Publication Date: 2022-04-05
梅鑫
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] In the prior art, there is no Chinese and Western medicine composition that suppresses novel coronavirus COVID-19; and a kind of pharmaceutical composition that suppresses novel coronavirus COVID-19 is required

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0006] In a Chinese and Western medicine composition for suppressing novel coronavirus of the present invention, the percentage by weight of each component medicine is:

[0007] β-shield podophyllotoxin, 0.01% to 75%;

[0008] harringtonine, 0.01% to 75%;

[0009] Forsythin, 0.01% to 75%;

[0010] Ritonavir, 0.01-65%;

[0011] Darunavir, 0.01% to 65%;

[0012] Raltegravir, 0.01% to 65%;

[0013] Recombinant human interferon α-2b, 0.01% to 50%;

[0014] Nimustine, 0.01% to 50%;

[0015] Oseltamivir, 0.01% to 55%;

[0016] Amantadine, 0.01% to 55%.

[0017] The total amount of the pharmaceutical composition of the present invention is 100%, and the percentage of each component drug in the pharmaceutical composition represents the ratio relationship between them. The weight unit is: grams.

[0018] The pharmacology of each component medicine is as follows:

[0019] β-Peltatin glucoside traditional Chinese medicine, derived from the rhizome of Podophyllum genus Berberida...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a traditional Chinese and western medicine pharmaceutical composition for inhibiting novel coronavirus, belonging to an antiviral traditional Chinese and western medicine pharmaceutical composition. The pharmaceutical composition comprises beta-podophyllopodophyllin, forsythin, ritonavir, amantadine and the like, has an inhibition effect on the activity of topoisomerase, can interfere the functions of nucleoprotein bodies, inhibit influenza virus neuraminidase and prevent RNA (Ribonucleic Acid) viruses from penetrating host cells, and has an inhibition effect on novel coronavirus COVID-19.

Description

technical field [0001] The present invention is a Chinese and Western medicine compound for inhibiting novel coronavirus, which belongs to an antiviral Chinese and Western medicine composition. The pharmaceutical composition has inhibitory effect on novel coronavirus COVID-19. Background technique [0002] In the prior art, there is no Chinese and Western medicine composition that suppresses novel coronavirus COVID-19; and a kind of pharmaceutical composition that suppresses novel coronavirus COVID-19 is required. Contents of the invention [0003] Purpose of the invention, a kind of Chinese and Western medicine composition that suppresses novel coronavirus of the present invention solves the technical problem that does not have a kind of Chinese and Western medicine composition that suppresses novel coronavirus COVID-19 in the prior art. A traditional Chinese and western medicine composition for inhibiting novel coronavirus can inhibit topoisomerase activity, interfere w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/21A61P31/14A61K31/13A61K31/215A61K31/34A61K31/365A61K31/427A61K31/505A61K31/513A61K31/55A61K31/7048
Inventor 梅鑫
Owner 梅鑫
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com